IMMUPHARMA PLC — AGM Information 2019

Jun 4, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9079A

Immupharma PLC

04 June 2019

4 JUNE 2019

ImmuPharma PLC

("ImmuPharma" or the "Company")

Notice of AGM and posting of Report & Accounts

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company confirms that the Annual Report and Accounts for the year ended 31 December 2018, and the Notice of Annual General Meeting has been posted to shareholders.

These documents are available, in electronic form, for download on the Company's website www.immupharma.co.uk.

ImmuPharma's Annual General Meeting will be held on Thursday 27 June at 10:30am (BST) at the offices of: Capital Access Group, 107 Cheapside, London, EC2V 6DN.

For further information please contact:

ImmuPharma PLC (www.immupharma.com)	+ 44 (0) 207 152 4080
Tim McCarthy, Chairman Dimitri Dimitriou, Chief Executive Officer
Lisa Baderoon, Head of Investor Relations	+ 44 (0) 7721 413496
SPARK Advisory Partners Limited (NOMAD) Neil Baldwin Vassil Kirtchev Stanford Capital Partners (Joint Broker) Patrick Claridge, John Howes SI Capital (Joint Broker) Nick Emerson	+44 (0) 203 368 8974 +44 (0) 203 815 8880 +44 (0) 1483 413500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DOCUORWRKOANRRR